Body temp questions..need answers please — Cancer Survivors Network

Body temp questions..need answers please — Cancer Survivors Network
The Cancer Survivors Network (CSN) is a peer support community for cancer patients, survivors, caregivers, families, and friends! CSN is a safe place to connect with others who share your interests and experiences.
Home› Head and Neck Cancer
Body temp questions..need answers please
lady4darknight CSN Member Posts: 90
July 2010 edited March 2014 in Head and Neck Cancer #1
Hi all...haven't been on for a bit since I went under my treatment and came home but now need some answer please. I had 20 Avian radiation treatments on my tumor and finished June 23rd. Go back on Aug.2nd to see what further treatment. Had a PEG tube placed and a Power Port. But here is my problem....I can't get my body temp to regulate. I am either freezing or sweating with no happy medium. Guys. I am in so. Missouri and it is hot and humid and I either have goosebumps and am wrapped tight or am sweating then get cold from the sweats. Has anyone else had this and how to you fix it? My other question is I seem to have no or very little saliva and this makes it difficult to eat but don't want to use my PEG if I don't have to. What is the best thing to help that and if I don't use my PEG how often do I need to flush it? Thanks for all help.
Debbie
0 Like Care
Comments
Kent Cass CSN Member Posts: 1,898 Member
July 2010 #2
Good to hear from you
Had wondered how things went for you in Tulsa.
Thyroid has a big influence on body temp. I'm only aware of feeling cold due to thyroid function, but hot may also be part of it.
Not uncommom to wash things down, due to lack of saliva, Debbie. Saliva glands do take a major hit w/treatment. Typical to adjust our food intake to fit the circumstances- trial and error. Ensure and Boost are good liquids- you need plenty of good calories in you/day. Fruit and vegetable produce is good, too.
As for the PEG flushes- did you get any big syringes? If so, wouldn't hurt to squirt 1/2-tube of water down the PEG every couple days. Am curious about your getting the Port- have they used it, yet? Typical for the Ports to be installed for treatment with pump(s), and the feeding tube for times when regular eating becomes too difficult. No surgery, other than the PEG and Port placements?
Was concerned about you, Debbie, as I know several others were, equally. Even if by PM, I would like an update on your status- important things the Drs. have told you about your battle with C, the specifics on your treatment, and how you're holding-up. Hope to get a response from you, Debbie.
Believe
kcass
0 Like Care
Skiffin16 CSN Member Posts: 8,305 Member
July 2010 #3
Temperature
Are you having Amifostine injections (eythol)... I had bad temperature swings when I was having those. When I stopped, no more problems....
Thyroid function is another variable as for fatigue, and body temperature. Have they tested you during blood labs (TSH testing)....
JG
0 Like Care
Scambuster CSN Member Posts: 970
July 2010 #4
Hot n' Cold
Hi Debbie,
Nice to hear you are finished treatments. I suffered the Hot n Cold thing for the last 2+ weeks of treatment and a week or two after. I then only really felt the cold and this went on for some time- about 2-3 months. As you are in summer over there, that shouldn't be too bad for you. I think many of us go through a similar trend.
I found the cold to be a problem (this was in mid spring so temps were a little cool) and since the doctors couldn't help I knew a lady who did 'energy healing' (or touch healing/natural healling), and I went to see her. Many may think it's rubbish but after 2 sessions with her, the condition improved 90%. I now don't feel the heat as much as most and now only very slightly more sensitive to the cold. Not really sure how it all works, don't care but it worked for me.
The consensus is this is related to the thyroid and that the Radiation causes some damage to the thyroid making it hard for you to regulate your body temperature.
On the dry mouth, this is a tough one and depending on how much and where the rads hit your mouth, you may or may not get back some or most of your saliva function. We have three mains pairs of salivary glands which produce the majority, but luckily there are a load of tiny ones spread throughout your mouth. If the major S 'Glands took a direct hit, the damage and effect may be permanent. I had the same dilemma and as the doctors just shook their heads - I went elsewhere. I have had about 8 sessions of acupuncture and have regained 10-15% of my saliva. While not a perfect result, it certainly does make things easier. I also take echinacea every day which is supposed to help too. I still need liquid (Water or soup) when I eat, and I 'lube up' my salads with olive oil, but if I keep my mouth closed, I can manage to keep my teeth wet.
Having enough saliva to moisten your mouth is critic for your teeth. I would recommend you try GC Mousse or a similar product. It is applied to the teeth in the evening before bed to protect them. You also need to brush after every meal and floss at least in the evening. Rigorous dental care is a must now. I use the Biotene mouthwash and toothpaste or a medicated or natural toothpaste (Avoid the Colgates etc).
Things should settle soon Debbie. You body had taken a beating so give it time to heal and the food it needs to do that.
Regds
Scambuster
0 Like Care
lady4darknight CSN Member Posts: 90
July 2010 #5
Kent Cass said:
Good to hear from you
Had wondered how things went for you in Tulsa.
Thyroid has a big influence on body temp. I'm only aware of feeling cold due to thyroid function, but hot may also be part of it.
Not uncommom to wash things down, due to lack of saliva, Debbie. Saliva glands do take a major hit w/treatment. Typical to adjust our food intake to fit the circumstances- trial and error. Ensure and Boost are good liquids- you need plenty of good calories in you/day. Fruit and vegetable produce is good, too.
As for the PEG flushes- did you get any big syringes? If so, wouldn't hurt to squirt 1/2-tube of water down the PEG every couple days. Am curious about your getting the Port- have they used it, yet? Typical for the Ports to be installed for treatment with pump(s), and the feeding tube for times when regular eating becomes too difficult. No surgery, other than the PEG and Port placements?
Was concerned about you, Debbie, as I know several others were, equally. Even if by PM, I would like an update on your status- important things the Drs. have told you about your battle with C, the specifics on your treatment, and how you're holding-up. Hope to get a response from you, Debbie.
Believe
kcass
Hello
Hi, Sorry I didn't update everyone but my treatments and everything happened so fast and then the surgeries to place the PEG and Port which I didn't expect just threw me for a loop. I have had a total of 5 surgeries to reduce the size of the tumor and had 20 rad treatments. I had to have that horrible mask made for my face and used for radiation treatments and I am claustrophobic really bad so I had a difficult time with my treatments. Since my treatments have stopped and I have been home, I have had a time of remembering things that happened. I looked at pictures I took of when my family visited me and I have no memory of any of that time. Is that normal? Seems like I have 3 weeks I can't remember. Total blackout.
Thanks for the info on my PEG. I will make sure to flush it daily. I ave some 60 cc syringes that I got so I will flush with 30 cc twice a day.
As for my Port, it was used for all my blood tests but other than that not at all. I have found no one here at home will not access it so I will have to make sure to get it flushed at the local hospital monthly.
I have had damage to my larynx and my epigilitos because of the size of my tumor. Both of them are laying flat. The drs. say my larynx will still interfere with my breathing so I may not get my trache removed. But I have noticed since my last sur


Chronic obstructive pulmonary disease (COPD) - Evidence | BMJ Best Practice US

Chronic obstructive pulmonary disease (COPD) - Evidence | BMJ Best Practice US
Skip to main contentSkip to search
English (US)EnglishPortuguês
Log in
Personal account
Access through your institution(Open Athens)
Subscribe
Access through your institution
Log in
English (US)EnglishPortuguês
Home
Search
Search
Home
About us
OverviewWhat is BMJ Best Practice?Our history
Key featuresClinical tools Local guidanceEarn CME/CPD pointsAccess anywhereOur appIntegration
Our Evidence approachTrusted contentUpdating process
Who we help
Best Practice for...CliniciansHospitalsMedical librariansMedical schoolsMedical studentsNursesPharmacistsPrimary careParamedicsTelehealth
How we help
Impact and effectivenessEvidence of effectiveness Global impactCustomer stories
Browse clinical content
Recent updates
Specialties
Try a free topic
Patient information
Videos
Calculators
What’s new
Clinical updates
News
Podcast
Access
Log in via...Personal subscription or user profileAccess through your institution
Access code
Subscribe
Free trial
How do I get access?
Download the app
Help
FAQs
How do I get access?
Contact us
Chronic obstructive pulmonary disease (COPD)
View PDF
 Menu Close
Overview 
Theory 
Diagnosis 
Management 
Follow up 
Resources 
Overview
Summary
Theory
Epidemiology
Etiology
Case history
Diagnosis
Approach
History and exam
Tests
Differentials
Criteria
Screening
Management
Approach
Treatment algorithm
Emerging
Prevention
Patient discussions
Follow up
Monitoring
Complications
Prognosis
Resources
Guidelines
Images and videos
References
Patient information
Calculators
Evidence
This topic is available for free
Evidence
This page contains a snapshot of featured content which highlights evidence addressing key clinical questions including areas of uncertainty. Please see the main topic reference list for details of all sources underpinning this topic.
BMJ Best Practice evidence tables
Evidence tables provide easily navigated layers of evidence in the context of specific clinical questions, using GRADE and a BMJ Best Practice Effectiveness rating. Follow the links at the bottom of the table, which go to the related evidence score in the main topic text, providing additional context for the clinical question. Find out more about our evidence tables.
VIEW ALL

What are the effects of integrated disease management (IDM) interventions for people with chronic obstructive pulmonary disease (COPD)?
This table is a summary of the analysis reported in a Cochrane Clinical Answer that focuses on the above important clinical question.
View the full source Cochrane Clinical Answer
Evidence A?
Confidence in the evidence is high or moderate to high where GRADE has been performed and the intervention is more effective/beneficial than the comparison for key outcomes.
Population: Adults with COPD
Intervention: IDM ᵃ
Comparison: Usual care (regular follow-up visits with healthcare providers)
Outcome
Effectiveness (BMJ rating)?
Confidence in evidence (GRADE)?
Quality of life (>6 to 15 months): St. George’s Respiratory Questionnaire (SGRQ) ᵇ
Favors intervention
Moderate
Functional exercise capacity (>6 to 15 months)
Favors intervention
Moderate
Respiratory‐related hospital admissions (12 months)
Favors intervention
High
All hospital admissions
Favors intervention
Moderate
Hospital days per patient (all causes)
Favors intervention
Moderate
Emergency Department visits
Favors intervention
Moderate
Number of patients experiencing ≥ 1 exacerbation
No statistically significant difference
GRADE assessment not performed for this outcome
Mortality
No statistically significant difference
GRADE assessment not performed for this outcome
Need for at least one course of oral steroids
No statistically significant difference
GRADE assessment not performed for this outcome
Need for at least one course of antibiotics
No statistically significant difference
GRADE assessment not performed for this outcome
Note
The Cochrane review which underpins this Cochrane Clinical Answer (CCA) notes that the effects of IDM are better in the short and medium term, and that the effect size was different between included studies and interventions. IDM should be carefully designed and evaluated, consisting of different components which are linked to the personal goals of the patient.
ᵃ Including organizational, professional, patient-directed, and financial interventions in primary, secondary, and tertiary healthcare settings. See CCA and the underlying Cochrane review for more information on specific interventions and the dominant components of the IDM programs.
ᵇ Although statistically significant, this result did not quite reach the minimum clinically important difference. The CCA also reports a subgroup analysis for quality of life measured by the Chronic Respiratory Questionnaire. However, this was only reported in two studies and the analysis was underpowered.
This evidence table is related to the following section/s:
Management Approach

How does umeclidinium compare with placebo for people with chronic obstructive pulmonary disease (COPD)?
This table is a summary of the analysis reported in a Cochrane Clinical Answer that focuses on the above important clinical question.
View the full source Cochrane Clinical Answer
Evidence A?
Confidence in the evidence is high or moderate to high where GRADE has been performed and the intervention is more effective/beneficial than the comparison for key outcomes.
Population: Adults with moderate-to-severe COPD
Intervention: Umeclidinium (once daily via a dry powder inhaler for 12-52 weeks)
Comparison: Placebo
Outcome
Effectiveness (BMJ rating)?
Confidence in evidence (GRADE)?
Number of participants with exacerbations requiring corticosteroids, antibiotics, or both at 52 weeks
Favors intervention
High
Quality of life at 24-52 weeks (measured by the St George's Respiratory Questionnaire [SGRQ])
Favors intervention
Moderate
Number of participants with hospital admissions due to COPD exacerbation at 52 weeks (measured by the Transitional Dyspnea Index [TDI])
No statistically significant difference
Low
Improvement in symptoms at 24 weeks
Favors intervention
High
Lung function at 4-52 weeks
Favors intervention
High
Nonfatal serious adverse events
No statistically significant difference
Moderate
Adverse events
No statistically significant difference
Moderate
This evidence table is related to the following section/s:
Treatment algorithm
Management Approach
Cochrane Clinical Answers
Cochrane Clinical Answers (CCAs) provide a readable, digestible, clinically focused entry point to rigorous research from Cochrane systematic reviews. They are designed to be actionable and to inform decision making at the point of care and have been added to relevant sections of the main Best Practice text.
What are the effects of integrated disease management (IDM) interventions for people with chronic obstructive pulmonary disease (COPD)?
Show me the answer
How does tiotropium compare with ipratropium bromide for people with chronic obstructive pulmonary disease (COPD)?
Show me the answer
How does umeclidinium bromide compare with placebo for people with chronic obstructive pulmonary disease (COPD)?
Show me the answer
How does a combined inhaler with once‐daily long‐acting beta2‐agonist (LABA) plus a long‐acting muscarinic antagonist (LAMA) compare with placebo for adults with chronic obstructive pulmonary disease (COPD)?
Show me the answer
How does long‐acting muscarinic antagonist (LAMA) plus long‐acting beta‐agonist (LABA) compare with LABA plus inhaled corticosteroid (ICS) for people with stable chronic obstructive pulmonary disease (COPD)?
Show me the answer
What are the benefits and harms of inhaled corticosteroids (ICS) in people with stable chronic obstructive pulmonary disease (COPD)?
Show me the answer
What are the effects of long‐acting inhaled therapies for adults with chronic obstructive pulmonary disease (COPD)?
Show me the answer
How do phosphodiesterase‐4 inhibitors


Valerie Novak - ACL Anthology

Valerie Novak - ACL Anthology
ACL Anthology
News(current)
FAQ(current)
Corrections(current)
Submissions(current)
GitHub
Valerie Novak
2022
pdf bib abs
RU-ADEPT: Russian Anonymized Dataset with Eight Personality Traits
C. Anton Rytting | Valerie Novak | James R. Hull | Victor M. Frank | Paul Rodrigues | Jarrett G. W. Lee | Laurel Miller-Sims
Proceedings of the Thirteenth Language Resources and Evaluation Conference
Social media has provided a platform for many individuals to easily express themselves naturally and publicly, and researchers have had the opportunity to utilize large quantities of this data to improve author trait analysis techniques and to improve author trait profiling systems. The majority of the work in this area, however, has been narrowly spent on English and other Western European languages, and generally focuses on a single social network at a time, despite the large quantity of data now available across languages and differences that have been found across platforms. This paper introduces RU-ADEPT, a dataset of Russian authors’ personality trait scores–Big Five and Dark Triad, demographic information (e.g. age, gender), with associated corpus of the authors’ cross-contributions to (up to) four different social media platforms–VKontakte (VK), LiveJournal, Blogger, and Moi Mir. We believe this to be the first publicly-available dataset associating demographic and personality trait data with Russian-language social media content, the first paper to describe the collection of Dark Triad scores with texts across multiple Russian-language social media platforms, and to a limited extent, the first publicly-available dataset of personality traits to author content across several different social media sites.
2021
pdf bib abs
Personality Trait Identification Using the Russian Feature Extraction Toolkit
James R. Hull | Valerie Novak | C. Anton Rytting | Paul Rodrigues | Victor M. Frank | Matthew Swahn
Proceedings of the International Conference on Recent Advances in Natural Language Processing (RANLP 2021)
Feature engineering is an important step in classical NLP pipelines, but machine learning engineers may not be aware of the signals to look for when processing foreign language text. The Russian Feature Extraction Toolkit (RFET) is a collection of feature extraction libraries bundled for ease of use by engineers who do not speak Russian. RFET’s current feature set includes features applicable to social media genres of text and to computational social science tasks. We demonstrate the effectiveness of the tool by using it in a personality trait identification task. We compare the performance of Support Vector Machines (SVMs) trained with and without the features provided by RFET; we also compare it to a SVM with neural embedding features generated by Sentence-BERT.
2018
pdf bib
Arabic Data Science Toolkit: An API for Arabic Language Feature Extraction
Paul Rodrigues | Valerie Novak | C. Anton Rytting | Julie Yelle | Jennifer Boutz
Proceedings of the Eleventh International Conference on Language Resources and Evaluation (LREC 2018)
2014
pdf bib
ArCADE: An Arabic Corpus of Auditory Dictation Errors
C. Anton Rytting | Paul Rodrigues | Tim Buckwalter | Valerie Novak | Aric Bills | Noah H. Silbert | Mohini Madgavkar
Proceedings of the Ninth Workshop on Innovative Use of NLP for Building Educational Applications
Search
Co-authors
Paul Rodrigues 4
C. Anton Rytting 4
Victor M. Frank 2
James R. Hull 2
Aric Bills 1
show all...
Jennifer Boutz 1
Tim Buckwalter 1
Jarrett G. W. Lee 1
Mohini Madgavkar 1
Laurel Miller-Sims 1
Noah H. Silbert 1
Matthew Swahn 1
Julie Yelle 1
Venues
lrec2
bea1
ranlp1
Fix author
ACL materials are Copyright © 1963–2026 ACL; other materials are copyrighted by their respective copyright holders. Materials prior to 2016 here are licensed under the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 International License. Permission is granted to make copies for the purposes of teaching and research. Materials published in or after 2016 are licensed on a Creative Commons Attribution 4.0 International License.
The ACL Anthology is managed and built by the ACL Anthology team of volunteers.
Site last built on 06 February 2026 at 10:32 UTC with commit 3edd046.


My Account - Реєстрація

My Account - Реєстрація
Jump to: Page Content, Site Navigation, Site Search
украї́нська мо́ва
English
Português (Brasil)
Español
中文(简体)
ქართული
Azərbaycanca
украї́нська мо́ва
Tiếng Việt
Русский
My Account
Початок роботи
Про Вас
Завершити
Будь ласка, введіть свою адресу електронної пошти, щоб ми могли визначити, чи є вже у Вас обліковий запис.
Email
Продовжити
Cookie settings
Контакти
Правила та умови сайту
Політика конфіденційності та використання кукі
© BMJ Publishing Group Limited 2026. Усі права захищено.


Háfnio e Nióbio Tabela Periódica

Háfnio e Nióbio Tabela Periódica
×
Háfnio
☒
Nióbio
☒
Top
ADD ⊕
Compare
Comparar Metais
metais de transição
Série actinide
série lantanídeos
Postar Transição Metal
metais alcalinos terrestres
Metais alcalinos
⌕
▼
X
Háfnio
X
Nióbio
Háfnio e Nióbio Tabela Periódica
Háfnio
Nióbio
Add ⊕
Resumo
Tabela Periódica
Fatos
usos
Físico
Químico
atômico
Mecânico
Magnético
Térmico
Todos
Tabela Periódica
Símbolo
Hf
Nb
Número grupo
45
0 17
👆🏻
Número período
65
2 7
👆🏻
Quadra
d
d
Família Elemento
Transição
Transição
Número CAS
74405867440031
7429905 54386242
👆🏻
Espaço grupo nome
P63/mmc
Im_ 3m
Espaço Grupo Número
194,00229,00
11 276
👆🏻
Comparar metais de transição » Mais
Háfnio vs Bóhrio
Háfnio vs Dúbnio
Háfnio vs Copernício
» Mais Comparar metais de transição
metais de transição » Mais
Rênio Metal
Seaborgium Metal
Hássio Metal
Rutherfórdio Metal
Bóhrio Metal
Dúbnio Metal
» Mais metais de transição
metais de transição » Mais
Copernício Metal
Tabela Pe... | Fatos | usos | Físico
Nióbio Metal
Tabela Pe... | Fatos | usos | Físico
Rutênio Metal
Tabela Pe... | Fatos | usos | Físico
Comparar metais de transição » Mais
Nióbio vs Seaborgium
Tabela Pe... | Fatos | usos | Físico
Nióbio vs Hássio
Tabela Pe... | Fatos | usos | Físico
Nióbio vs Rutherfórdio
Tabela Pe... | Fatos | usos | Físico
English
Español
日本語
français
Deutsche
italiano
한국어
Polskie
हिंदी
मराठी
中文
Dutch
Türk
Română
Tiếng Việt
bahasa Indonesia
Jawa
Home |
About |
Contact |
Disclaimer |
Terms of Use |
Privacy Policy
© 2015 - 2026 www.compareusvista.com
Developed & Maintained by softUsvista Inc.


Report of the cholera at Sacramento in 1852: its analogy if not identity with malignant congestive intermittent : the attendant meteorological phen...

Report of the cholera at Sacramento in 1852: its analogy if not identity with malignant congestive intermittent : the attendant meteorological phenomena : history, pathology and treatment of the disease : a letter to the editor - Digital Collections - National Library of Medicine
Skip to search Skip to main content
An official website of the United States government. Here’s how you know
Official websites use .gov
A .gov website belongs to an official government organization in the United States.
Secure .gov websites use HTTPS
A lock ( Lock
A locked padlock ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.
search for
Search
About
Help
Web Service
Report of the cholera at Sacramento in 1852: its analogy if not identity with malignant congestive intermittent : the attendant meteorological phenomena : history, pathology and treatment of the disease : a letter to the editor
Report of the cholera at Sacramento in 1852: its analogy if not identity with malignant congestive intermittent : the attendant meteorological phenomena : history, pathology and treatment of the disease : a letter to the editor
Collection:
Cholera Online, 1817 to 1923
Medicine in the Americas, 1610-1920
Author(s):
Logan, Thos. M. (Thomas Muldrup), 1808-1876
Publication:
[New Orleans? : s.n., 1853?]
Language(s):
English
Format:
Text
Subject(s):
Cholera
Disease Outbreaks
Meteorological Concepts
California
Copyright:
The National Library of Medicine believes this item to be in the public domain (More information)
Extent:
p. 488-500
NLM Unique ID:
34711310R (See catalog record)
Permanent Link:
http://resource.nlm.nih.gov/34711310R
View Book
Download
Book (PDF) OCR (Text) Metadata (Dublin Core)
Connect with NLM
National Library of Medicine
8600 Rockville Pike
Bethesda, MD 20894
Web Policies
FOIA
HHS Vulnerability Disclosure
NLM Support Center
Accessibility
Careers
NLM | NIH | HHS | USA.gov


Digital Collections - National Library of Medicine

Digital Collections - National Library of Medicine
Skip to search Skip to main content
An official website of the United States government. Here’s how you know
Official websites use .gov
A .gov website belongs to an official government organization in the United States.
Secure .gov websites use HTTPS
A lock ( Lock
A locked padlock ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.
search for
Search
About
Help
Web Service
« Previous Next »
A-Z Sort Numerical Sort
Titles
×
All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
« Previous Next »
A-Z Sort Numerical Sort
Connect with NLM
National Library of Medicine
8600 Rockville Pike
Bethesda, MD 20894
Web Policies
FOIA
HHS Vulnerability Disclosure
NLM Support Center
Accessibility
Careers
NLM | NIH | HHS | USA.gov


Sahajpreet Singh - ACL Anthology

Sahajpreet Singh - ACL Anthology
ACL Anthology
News(current)
FAQ(current)
Corrections(current)
Submissions(current)
GitHub
Sahajpreet Singh
2024
pdf bib abs
Hate Personified: Investigating the role of LLMs in content moderation
Sarah Masud | Sahajpreet Singh | Viktor Hangya | Alexander Fraser | Tanmoy Chakraborty
Proceedings of the 2024 Conference on Empirical Methods in Natural Language Processing
For subjective tasks such as hate detection, where people perceive hate differently, the Large Language Model’s (LLM) ability to represent diverse groups is unclear. By including additional context in prompts, we comprehensively analyze LLM’s sensitivity to geographical priming, persona attributes, and numerical information to assess how well the needs of various groups are reflected. Our findings on two LLMs, five languages, and six datasets reveal that mimicking persona-based attributes leads to annotation variability. Meanwhile, incorporating geographical signals leads to better regional alignment. We also find that the LLMs are sensitive to numerical anchors, indicating the ability to leverage community-based flagging efforts and exposure to adversaries. Our work provides preliminary guidelines and highlights the nuances of applying LLMs in culturally sensitive cases.
pdf bib abs
Intent-conditioned and Non-toxic Counterspeech Generation using Multi-Task Instruction Tuning with RLAIF
Amey Hengle | Aswini Padhi | Sahajpreet Singh | Anil Bandhakavi | Md Shad Akhtar | Tanmoy Chakraborty
Proceedings of the 2024 Conference of the North American Chapter of the Association for Computational Linguistics: Human Language Technologies (Volume 1: Long Papers)
Counterspeech, defined as a response to mitigate online hate speech, is increasingly used as a non-censorial solution. The effectiveness of addressing hate speech involves dispelling the stereotypes, prejudices, and biases often subtly implied in brief, single-sentence statements or abuses. These expressions challenge language models, especially in seq2seq tasks, as model performance typically excels with longer contexts. Our study introduces CoARL, a novel framework enhancing counterspeech generation by modeling the pragmatic implications underlying social biases in hateful statements. The first two phases of CoARL involve sequential multi-instruction tuning, teaching the model to understand intents, reactions, and harms of offensive statements, and then learning task-specific low-rank adapter weights for generating intent-conditioned counterspeech. The final phase uses reinforcement learning to fine-tune outputs for effectiveness and nontoxicity. CoARL outperforms existing benchmarks in intent-conditioned counterspeech generation, showing an average improvement of ∼3 points in intent-conformity and ∼4 points in argument-quality metrics. Extensive human evaluation supports CoARL’s efficacy in generating superior and more context-appropriate responses compared to existing systems, including prominent LLMs like ChatGPT.
Search
Co-authors
Tanmoy Chakraborty 2
Md. Shad Akhtar 1
Anil Bandhakavi 1
Alexander Fraser 1
Viktor Hangya 1
show all...
Amey Hengle 1
Sarah Masud 1
Aswini Padhi 1
Venues
emnlp1
naacl1
Fix author
ACL materials are Copyright © 1963–2026 ACL; other materials are copyrighted by their respective copyright holders. Materials prior to 2016 here are licensed under the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 International License. Permission is granted to make copies for the purposes of teaching and research. Materials published in or after 2016 are licensed on a Creative Commons Attribution 4.0 International License.
The ACL Anthology is managed and built by the ACL Anthology team of volunteers.
Site last built on 06 February 2026 at 10:32 UTC with commit 3edd046.


Primary Care in Rochester and Kasson

Primary Care in Rochester and Kasson
Search
Twitter
Facebook
Pinterest
YouTube
Home
Find a Clinic
Find a Job
Log in to Patient Account
Home
Featured Stories
Color Your Way
Primary Care in Rochester and Kasson
Care Team
Locations / Hours
Care Options
Primary Care
Primary Care On Demand
Need Care Now?
Prevention & Wellness
Health Forms
Features
Classes / Events
Featured Stories
Featured Videos
FAQs
Contact Us
Find a Study
Color your way to 5 a day
7/23/2018 by Rose Prissel, MS, RDN, LD
With fresh, in-season fruits and vegetables flooding into supermarkets and local farmers markets, it's a perfect time to practice and have fun "painting" your plate with color.
There are thousands of health-promoting phytochemicals found in plants. Researchers are just beginning to understand how they work to improve our health. But they do know it's important to eat a wide variety of colorful fruits and veggies to reap those health benefits.
Putting a rainbow of colors on your plate or in your lunch bag can make it easier to eat the five to nine services of fruits and vegetables recommended for every day. Painting your plate starts at the supermarket or farmers market. When shopping, look for an array of colors, choosing ones you and your family love and maybe experimenting with something new.
Here are some ideas for fruits and veggies to help you build your healthy-eating paint box:
Red: Strawberries, raspberries, cherries, watermelon, apples, radishes, tomatoes, red kidney beans, red peppers (spicy or sweet), red-skinned potatoes
Orange: Oranges, apricots, peaches, cantaloupe, mangoes, sweet potatoes, acorn squash, pumpkin, summer squash, carrots
Yellow: Lemons, pineapple, golden apples, bananas, starfruit, yellow tomatoes, sweet corn, yellow peppers, summer squash, golden beets
Green: Kiwi fruit, green grapes, avocados, Granny Smith apples, honeydew melon, spinach, green beans, broccoli, Brussels sprouts, snap peas
Blue/purple. Blueberries, blackberries, boysenberries, black seedless grapes, plums, raisins, purple cabbage, eggplant, purple potatoes, radicchio
White. Grapefruit, pears, baking potatoes, onions, mushrooms, jicama, cauliflower, navy or cannelloni beans, parsnips
Fresh fruits and veggies that are in season can be easier on your food budget. And remember that frozen produce is just as nutrient-packed as fresh and often can be more affordable.
Start your plate painting with these easy, colorful and summery recipes.
Grilled Fruit Chunks
Cut peaches, pears, apples, pineapple or a combination of these fruits into chunks. Toss with a little canola oil, sprinkle with cinnamon and thread onto skewers. Wrap in foil and grill over low heat for 3 to 5 minutes.
Pasta Primavera
Cook whole-grain pasta. Steam cut-up broccoli, cauliflower, carrots and green peas. Stir in chunks of fresh tomatoes and torn-up fresh basil. spoon the veggies over the pasta. Drizzle with a little light or no-calorie Italian dressing and sprinkle with Parmesan cheese.
Rose Prissel, MS, RDN, LD, is a dietitian at Mayo Clinic working in pediatric and adult nutrition, with a focus on preventive care, sports nutrition and weight management.
About Mayo Clinic
Employees
Find a job
Twitter
Facebook
Pinterest
YouTube
Mayo Clinic is a not-for-profit organization. Make a donation.
Patient Care & Health Info
Healthy Lifestyle
Symptoms A-Z
Diseases & Conditions A-Z
Tests & Procedures A-Z
Drugs & Supplements A-Z
Appointments
Patient & Visitor Guide
Patient Online Services
Departments & Centers
Doctors & Medical Staff
Medical Departments & Centers
Research Centers & Programs
About Mayo Clinic
Contact Mayo Clinic
Research
Explore Research Labs
Find Clinical Trials
Research Faculty
Postdoctoral Fellowships
Discovery's Edge Magazine
Search Publications
Training Grant Positions
Education
Mayo Clinic Alix School of Medicine
Mayo Clinic School of Graduate Medical Education
Mayo Clinic School of Continuous Professional Development
Mayo Clinic School of Health Sciences
Mayo Clinic Graduate School of Biomedical Sciences
Alumni Center
For Medical Professionals
Provider Relations
Online Services for Referring Physicians
Video Center
Publications
Mayo Medical Laboratories
Products & Services
Healthy Living Program
Mayo Clinic Press
Mayo Clinic Health Letter
Medical Products
Population Health and Wellness Programs
Health Plan Administration
Medical Laboratory Services
Any use of this site constitutes your agreement to the Terms and Conditions and Privacy Policy linked below.
Terms and Conditions
Privacy Policy
Notice of Privacy Practices
Notice of Nondiscrimination
A single copy of these materials may be reprinted for noncommercial personal use only. "Mayo," "Mayo Clinic," "MayoClinic.org," "Mayo Clinic Healthy Living," and the triple-shield Mayo Clinic logo are trademarks of Mayo Foundation for Medical Education and Research
© 1998-2023 Mayo Foundation for Medical Education and Research (MFMER). All rights reserved.


SLC6A19 gene: MedlinePlus Genetics

SLC6A19 gene: MedlinePlus Genetics
Skip navigation
An official website of the United States government
Here’s how you know
Here’s how you know
Official websites use .gov
A .gov website belongs to an official government organization in the United States.
Secure .gov websites use HTTPS
A lock ( Lock
Locked padlock icon ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.
National Library of Medicine
Menu
Health Topics
Drugs & Supplements
Genetics
Medical Tests
Medical Encyclopedia
About MedlinePlus
Search
Search MedlinePlus
GO
About MedlinePlus
What's New
Site Map
Customer Support
Health Topics
Drugs & Supplements
Genetics
Medical Tests
Medical Encyclopedia
You Are Here:
Home →
Genetics →
Genes →
SLC6A19 gene
URL of this page: https://medlineplus.gov/genetics/gene/slc6a19/
SLC6A19 gene
solute carrier family 6 member 19
To use the sharing features on this page, please enable JavaScript.
Normal Function
The SLC6A19 gene provides instructions for making a protein called system B(0) neutral amino acid transporter 1 (B0AT1). This protein transports certain protein building blocks (amino acids), namely those with a neutral charge, into cells. B0AT1 is found primarily in the membrane of intestinal cells that make up the brush border, which lines the walls of the intestine and absorbs nutrients from food. B0AT1 transports the neutral amino acids from food into intestinal cells; from there the amino acids are released into the bloodstream to be used by the body. B0AT1 is also found in the membrane of kidney cells, specifically in cells of the proximal tubules, which are structures that help to reabsorb nutrients and other materials into the blood and excrete unneeded substances into the urine. In the kidneys, B0AT1 reabsorbs neutral amino acids into the bloodstream so they are not released in urine.
Health Conditions Related to Genetic Changes
Hartnup disease
At least 23 mutations in the SLC6A19 gene have been found to cause Hartnup disease. This condition is characterized by increased levels of amino acids in the urine (aminoaciduria). Some individuals have episodes during which they exhibit skin rashes or movement or cognitive problems. Most of the mutations that cause Hartnup disease change single amino acids in the B0AT1 protein, reducing its activity. A mutation that has been identified in multiple affected families replaces the amino acid aspartic acid with the amino acid asparagine at position 173 in the protein (written as Asp173Asn or D173N).
The reduced B0AT1 activity leads to large amounts of neutral amino acids being removed from the body as waste. As a result, affected individuals are lacking (deficient) in certain amino acids and vitamins. Most affected people get the nutrients they need from a well-balanced diet. However, some individuals are nutrient-deficient due to their diet, illness, stress, or a variety of other reasons and can develop skin rashes or movement or psychiatric problems. Researchers believe that many of these features are related to a deficiency of vitamin B3 (niacin) and one of its main components, the amino acid tryptophan.
More About This Health Condition
Other Names for This Gene
B0AT1
HND
sodium-dependent amino acid transporter system B0
sodium-dependent neutral amino acid transporter B(0)AT1
solute carrier family 6 (neutral amino acid transporter), member 19
system B(0) neutral amino acid transporter AT1
system B0 neutral amino acid transporter
Additional Information & Resources
Tests Listed in the Genetic Testing Registry
Tests of SLC6A19
Scientific Articles on PubMed
PubMed
Catalog of Genes and Diseases from OMIM
SOLUTE CARRIER FAMILY 6 (NEUROTRANSMITTER TRANSPORTER), MEMBER 19; SLC6A19
Gene and Variant Databases
NCBI Gene
ClinVar
References
Azmanov DN, Rodgers H, Auray-Blais C, Giguere R, Bailey C, Broer S, Rasko JE, Cavanaugh JA. Persistence of the common Hartnup disease D173N allele in populations of European origin. Ann Hum Genet. 2007 Nov;71(Pt 6):755-61. doi: 10.1111/j.1469-1809.2007.00375.x. Epub 2007 Jun 7. Citation on PubMed
Broer S. The role of the neutral amino acid transporter B0AT1 (SLC6A19) in Hartnup disorder and protein nutrition. IUBMB Life. 2009 Jun;61(6):591-9. doi: 10.1002/iub.210. Citation on PubMed
Camargo SM, Singer D, Makrides V, Huggel K, Pos KM, Wagner CA, Kuba K, Danilczyk U, Skovby F, Kleta R, Penninger JM, Verrey F. Tissue-specific amino acid transporter partners ACE2 and collectrin differentially interact with hartnup mutations. Gastroenterology. 2009 Mar;136(3):872-82. doi: 10.1053/j.gastro.2008.10.055. Epub 2008 Oct 29. Citation on PubMed
Kleta R, Romeo E, Ristic Z, Ohura T, Stuart C, Arcos-Burgos M, Dave MH, Wagner CA, Camargo SR, Inoue S, Matsuura N, Helip-Wooley A, Bockenhauer D, Warth R, Bernardini I, Visser G, Eggermann T, Lee P, Chairoungdua A, Jutabha P, Babu E, Nilwarangkoon S, Anzai N, Kanai Y, Verrey F, Gahl WA, Koizumi A. Mutations in SLC6A19, encoding B0AT1, cause Hartnup disorder. Nat Genet. 2004 Sep;36(9):999-1002. doi: 10.1038/ng1405. Epub 2004 Aug 1. Citation on PubMed
Seow HF, Broer S, Broer A, Bailey CG, Potter SJ, Cavanaugh JA, Rasko JE. Hartnup disorder is caused by mutations in the gene encoding the neutral amino acid transporter SLC6A19. Nat Genet. 2004 Sep;36(9):1003-7. doi: 10.1038/ng1406. Epub 2004 Aug 1. Citation on PubMed
Genomic Location
The SLC6A19 gene is found on chromosome 5.
Related Health Topics
Genes and Gene Therapy
Genetic Disorders
MEDICAL ENCYCLOPEDIA
Genes
Genetics
Understanding Genetics
What is DNA?
What is a gene?
What is a gene variant and how do variants occur?
Disclaimers
MedlinePlus links to health information from the National Institutes of Health and other federal government agencies. MedlinePlus also links to health information from non-government Web sites. See our disclaimer about external links and our quality guidelines.
The information on this site should not be used as a substitute for professional medical care or advice. Contact a health care provider if you have questions about your health.
Learn how to cite this page
About MedlinePlus
What's New
Site Map
Customer Support
Subscribe to RSS
Connect with NLM
NLM Web Policies
Copyright
Accessibility
Guidelines for Links
Viewers & Players
HHS Vulnerability Disclosure
MedlinePlus Connect for EHRs
For Developers
National Library of Medicine 8600 Rockville Pike, Bethesda, MD 20894 U.S. Department of Health and Human Services National Institutes of Health
Last updated May 1, 2016


Tubular wells and wells in general, as a source of water supply for domestic purposes - Digital Collections - National Library of Medicine

Tubular wells and wells in general, as a source of water supply for domestic purposes - Digital Collections - National Library of Medicine
Skip to search Skip to main content
An official website of the United States government. Here’s how you know
Official websites use .gov
A .gov website belongs to an official government organization in the United States.
Secure .gov websites use HTTPS
A lock ( Lock
A locked padlock ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.
search for
Search
About
Help
Web Service
Tubular wells and wells in general, as a source of water supply for domestic purposes
Tubular wells and wells in general, as a source of water supply for domestic purposes
Collection:
Medicine in the Americas, 1610-1920
Author(s):
Hoadley, J. C. (John Chipman), 1818-1886 author
Publication:
[Boston?] : [publisher not identified], [1884?]
Language(s):
English
Format:
Text
Subject(s):
Water Wells
Copyright:
The National Library of Medicine believes this item to be in the public domain. (More information)
Extent:
36 pages, 10 leaves of plates (some folded)
Illustrations:
Illustrations and Plates
NLM Unique ID:
101190994 (See catalog record)
OCLC no.:
53091334
Permanent Link:
http://resource.nlm.nih.gov/101190994
View Book
Download
Book (PDF) OCR (Text) Metadata (Dublin Core)
Connect with NLM
National Library of Medicine
8600 Rockville Pike
Bethesda, MD 20894
Web Policies
FOIA
HHS Vulnerability Disclosure
NLM Support Center
Accessibility
Careers
NLM | NIH | HHS | USA.gov


Models – Hugging Face

Models – Hugging Face
Hugging Face
Models
Datasets
Spaces
Community
Docs
Enterprise
Pricing
Log In
Sign Up
Edit Models filters
Main
Tasks
Libraries
Languages
Licenses
Other 1
Apps
llama.cpp
LM Studio
Jan
Draw Things
DiffusionBee
Jellybox
JoyFusion
LocalAI
vLLM
Ollama
MLX LM
Docker Model Runner
Lemonade
SGLang
Inference Providers
Select all
Groq
Novita
Cerebras
SambaNova
Nscale
fal
Hyperbolic
Together AI
Fireworks
Featherless AI
Zai
Replicate
Cohere
Scaleway
Public AI
OVHcloud AI Endpoints
HF Inference API
WaveSpeed
Misc
Reset Misc
bigcode/starcoderdata
Inference Endpoints
text-generation-inference
Eval Results (legacy)
text-embeddings-inference
Merge
4-bit precision
custom_code
8-bit precision
Mixture of Experts
Carbon Emissions
Eval Results
Apply filters
Models
869
Full-text search
Inference Available
Edit filters
Sort: Trending
Active filters: bigcode/starcoderdata
Clear all
TinyLlama/TinyLlama-1.1B-Chat-v1.0
Text Generation • 1B • Updated Mar 17, 2024 • 1.63M • 1.52k
BlinkDL/rwkv7-g1
Text Generation • Updated 6 days ago • 162
or4cl3ai/Aiden_t5
Text Generation • Updated Oct 6, 2023 • 874 • 20
TheBloke/TinyLlama-1.1B-Chat-v1.0-GGUF
1B • Updated Dec 31, 2023 • 118k • 211
BSC-LT/ALIA-40b
Text Generation • 40B • Updated Oct 22, 2025 • 94 • 88
BlinkDL/rwkv-7-world
Text Generation • Updated May 31, 2025 • 107
JetBrains/Mellum-4b-dpo-all-gguf
4B • Updated Oct 1, 2025 • 151 • 5
TheBloke/TinyLlama-1.1B-Chat-v0.3-AWQ
Text Generation • 1B • Updated Nov 9, 2023 • 81.6k • 4
croissantllm/CroissantLLMChat-v0.1-GGUF
Text Generation • 1B • Updated Apr 29, 2024 • 71 • 4
ibm-granite/granite-34b-code-base-8k
Text Generation • 34B • Updated Sep 2, 2024 • 58 • 20
JetBrains/Mellum-4b-base
Text Generation • 4B • Updated May 7, 2025 • 2.24k • 436
JetBrains/Mellum-4b-sft-python
Text Generation • 4B • Updated May 19, 2025 • 24 • 55
JetBrains/Mellum-4b-base-gguf
4B • Updated May 7, 2025 • 503 • 38
microsoft/NextCoder-32B
Text Generation • 33B • Updated Jun 12, 2025 • 258 • • 67
JetBrains/Mellum-4b-sft-kotlin
Text Generation • 4B • Updated May 19, 2025 • 45 • 21
mradermacher/NextCoder-7B-GGUF
8B • Updated Jul 13, 2025 • 150 • 3
mlx-community/salamandra-7b-instruct-mlx-bf16
Text Generation • Updated Aug 21, 2025 • 12 • 1
JetBrains/Mellum-4b-dpo-python-gguf
4B • Updated Oct 1, 2025 • 63 • 4
mradermacher/Mellum-4b-dpo-all-i1-GGUF
4B • Updated Dec 6, 2025 • 185 • 1
Salesforce/codegen25-7b-mono_P
Text Generation • Updated Jan 31, 2025 • 124 • 31
openlm-research/open_llama_7b_v2
Text Generation • Updated Jul 7, 2023 • 1.91k • 122
Salesforce/codegen25-7b-instruct_P
Text Generation • Updated Jan 31, 2025 • 39 • 37
Salesforce/codegen25-7b-multi_P
Text Generation • Updated Jan 31, 2025 • 351 • 139
openlm-research/open_llama_7b_v2_easylm
Updated Jul 7, 2023 • 4
openlm-research/open_llama_3b_v2
Text Generation • Updated Jul 16, 2023 • 18.1k • 160
openlm-research/open_llama_3b_v2_easylm
Updated Jul 16, 2023 • 4
TheBloke/Codegen25-7B-mono-GPTQ
Text Generation • 7B • Updated Aug 21, 2023 • 4 • 8
jamesdborin/ct2-int8-open-llama-7b-v2
Text Generation • Updated Jul 26, 2023 • 1
BlinkDL/rwkv-5-world
Text Generation • Updated Apr 3, 2024 • 269
stabilityai/stablecode-completion-alpha-3b
Text Generation • Updated Aug 8, 2023 • 44 • 117
Previous
1
2
3
...
29
Next
System theme
Company
TOS Privacy About Careers
Website
Models Datasets Spaces Pricing Docs


Subjects: House Calls - Digital Collections - National Library of Medicine Search Results

Subjects: House Calls - Digital Collections - National Library of Medicine Search Results
Skip to search Skip to main content Skip to first result
An official website of the United States government. Here’s how you know
Official websites use .gov
A .gov website belongs to an official government organization in the United States.
Secure .gov websites use HTTPS
A lock ( Lock
A locked padlock ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.
search for
Search
About
Help
Web Service
Search
Search Constraints
Start Over You searched for: Subjects House Calls ✖ Remove constraint Subjects: House Calls
1 - 14 of 14
Sort by relevance
relevance title
Number of results to display per page
50 per page per page
10 per page 20 per page 50 per page 100 per page
Search Results
1. A simple device for sterilizing in private houses
Author(s):
Ashton, William Easterly, 1859-1933 author
Publication:
[Philadelphia?] : [publisher not identified], [1894?]
Subject(s):
Sterilization -- instrumentation
House Calls
2. Bringing primary care home: the Medical House Call Program at MedStar Washington Hospital Center
Author(s):
Klein, Sarah, author
Hostetter, Martha, author
McCarthy, Douglas, author
Publication:
[New York, N.Y.] : Commonwealth Fund, July 2016
Subject(s):
Ambulatory Care -- methods
Health Services for the Aged
Health Services Needs and Demand
House Calls
Primary Health Care
United States
3. Maintenance of an aseptic technique in gynecological operations outside of hospitals
Author(s):
Robb, Hunter, 1863-1940 author
Publication:
[Baltimore?] : [publisher not identified], [1893?]
Subject(s):
Gynecologic Surgical Procedures
Asepsis -- methods
House Calls
4. Antiseptic surgery in the country
Author(s):
Wheeler, John Brooks, 1853-1942
Publication:
Philadelphia : Medical Press Co., 1889
Subject(s):
Surgical Procedures, Operative
Antisepsis
House Calls
5. Surgery on the wing: three successful abdominal sections
Author(s):
Long, John Wesley, 1859-1926 author
Publication:
[Charlotte?] : [publisher not identified], [1895?]
Subject(s):
Appendicitis -- surgery
Ovarian Cysts -- surgery
Adnexal Diseases -- surgery
House Calls
6. [Teddy bears dressed as a nurse, a doctor, and a patient]
Author(s):
Neave, Jeremy, photographer
Publication:
Waddesdon, Bucks. : Perspectives Photographics, [between 1950 and 1999?]
Subject(s):
Nurses
House Calls
Physicians
Play and Playthings
England
7. Answering the call: when you are sick send for the Metropolitan nurse
Publication:
New York : Metropolitan Life Insurance Company, [between 1900 and 2000]
Subject(s):
Nurses
House Calls
Insurance, Life
United States
8. Wintry days offer no obstacles to the nurse in the perfomrance of her duties
Publication:
[Scotland?] : [publisher not identified], [1927?]
Subject(s):
Nurses
House Calls
9. [Services of a Queen's nurse for the aged]
Publication:
London : Raphael Tuck & Sons, [between 1900 and 1950]
Subject(s):
Nurses
Geriatric Nursing
Health Services for the Aged
House Calls
England
10. [Nurse helping a young girl]
Publication:
London : Raphael Tuck & Sons, [1927?]
Subject(s):
Nurses
House Calls
11. His first case
Author(s):
Drayton, Grace G. (Grace Gebbie) artist
Publication:
Hamburg : Alfred Schweizer, [1910?]
Subject(s):
Child, Preschool
House Calls
Nurses
Play and Playthings
12. A queen's nurse on her village round
Publication:
London : Raphael Tuck & Sons, [1927?]
Subject(s):
Nurses
House Calls
13. Sight tests at home
Publication:
[England] : H.M.S.O., 1990
Subject(s):
Vision Tests
Eligibility Determination
House Calls
State Medicine
United Kingdom
14. "A Doctor Quick!"
Publication:
[United States] : Bell Telephone, [1905?]
Subject(s):
Telephone
House Calls
American Telephone and Telegraph Company.
Refine by:
Show facets Hide facets
Formats
Still image9
Text5
Collections
Images from the History of Medicine (IHM)9
Medicine in the Americas, 1610-19204
Health Policy and Services Research1
Subjects
House Calls✖[remove]14
Nurses7
England2
Health Services for the Aged2
Play and Playthings2
more Subjects »
Authors
Ashton, William Easterly, 1859-1933 author1
Drayton, Grace G. (Grace Gebbie) artist1
Hostetter, Martha, author1
Klein, Sarah, author1
Long, John Wesley, 1859-1926 author1
more Authors »
Titles
"A Doctor Quick!"1
A queen's nurse on her village round1
A simple device for sterilizing in private houses1
Answering the call: when you are sick send for the Metropolitan nurse1
Antiseptic surgery in the country1
more Titles »
Languages
English14
Genre
Postcard8
Advertisement1
Case Reports1
Poster1
Technical Report1
Copyright
Public domain8
Copyright may apply7
Dates by Range
1850-18994
1900-19497
1950-19993
2000 and later2
Publication Year
Begin
End
1000 to 10990
1100 to 11990
1200 to 12990
1300 to 13990
1400 to 14990
1500 to 15990
1600 to 16990
1700 to 17990
1800 to 18994
1900 to 19999
2000 to 20261
Connect with NLM
National Library of Medicine
8600 Rockville Pike
Bethesda, MD 20894
Web Policies
FOIA
HHS Vulnerability Disclosure
NLM Support Center
Accessibility
Careers
NLM | NIH | HHS | USA.gov


Anastrozole — Community Discussion Forums

Anastrozole — Community Discussion Forums
Home› The Breastcancer.org Community Forum› In treatment› Hormonal Therapy - Before, During, and After
Come join others currently navigating treatment in our weekly Virtual Support Groups! See times and register here.
Anastrozole
lmruss Posts: 1
April 2025 edited April 2025 in Hormonal Therapy - Before, During, and After
Hi. looking for opinions. I was diagnosed with invasive carcinoma of breast the breast. My tumor was 4mm. I was HER negative. Estrogen Receptor 60%, Progesterone Receptor 40%, KI67 proliferation no longer marker 3%. I had a lumpectomy. When they did the surgery the tumor was already gone from the biopsy. Nothing spread to my lymph nodes They didn’t do testing for an onco type score because it was too small & the tumor was gone during the surgery. I did 20 rounds of radiation. Would you do the hormone therapy in this situation? My genetic testing also came back good . Really trying to decide what to do. Any feedback is greatly appreciated!
Tagged:
Arimidex (anastrozole)
0
Comments
exbrnxgrl Posts: 5,613
April 2025
Imruss,
This question comes up a lot. My first suggestion is to bring your concerns about this to your mo and really be honest about why you’re hesitating. Genetic testing is largely irrelevant since only a minority of bc cases are linked to genetic mutations. What they’re recommending, Anastrozole, is pretty much standard of care for your situation.
When reading through bco you are much more likely to find posts by folks having problems and side effects from AI’s. Those who have no, few, or diminishing side effects tend not to post nearly as much. Lastly, there is simply no way to predict in advance who will or won’t have side effects or the severity. I took each of the AI’s at one time or another for well over 12 years but managed the side effects for the most part ( about to start again, too!). Many people choose to start and are surprised by how well things go, others, not so much so they choose to stop.
For me, the bottom line when asking this question is if you will feel regret if you don’t take it and have a recurrence later. Clearly this is a very individual choice but it is always your choice. Take care
0
moderators Posts: 9,847
April 2025
Hi <USER_36>, and welcome to Breastcancer.org!
We're so sorry for the reasons that bring you here, but we're really glad you've found us. As you can already see, our community is a wonderful source of advice, information, encouragement, and support — we're all here for you!
<USER_37> offers a great response, and some information to ponder.
There's also some good insight here, to explain why it's beneficial to take hormonal therapy to prevent recurrence risk:
https://www.breastcancer.org/treatment/hormonal-therapy/refusing-hormone-therapy
We hope this helps!
—The Mods
0
sundevilfan68 Posts: 2
April 2025
I take anastrozole. I am in a similar situation. I had what was said to be 8mm ER+ PR- HER2- ILC, but was 4mm after biopsy. I had a lumpectomy and brachytherapy (targeted radiation) no chemo. No cancer in my lymph nodes. Nothing showed up on genetic testing. I don't like the side effects of the medication, but they are not enough to make me stop the med. I know that I want to do all I can do to lessen my risk of recurrence. You could always try it out and if the side effects are too much, switch the med or discontinue at that time.
0
Categories
All Categories
1.4K Concerned about my risk
1.7K Connect with others like me
2K In treatment
606 Managing life with cancer
156 Finished treatment
836 Living with metastatic disease
53 Caring for someone
294 Tributes
39 Discussion forum resources
Join Us on Zoom: Upcoming virtual support groups. Read more...
Share more about you! Fill out your profile.
Your donation goes directly to what you read, hear, and see on Breastcancer.org.
Donate
Stay informed with emails from us
By submitting my email, I agree to receive newsletters from Breastcancer.org
About Us
Mission Team Media Financials
Get In Touch
Contact us Job postings FAQ Guidelines Abbreviations
You can help
Ways to give Donate Host a fundraiser Partnerships
F O U R - S T A R Breastcancer.org is a registered 501(c)(3) nonprofit organization.
EIN is 23-3082851.
© 2025 Breastcancer.org - All rights reserved. 40 E Montgomery Avenue, 4th Floor Ardmore, PA 19003. Breastcancer.org does not provide medical advice, diagnosis or treatment. See additional information.
Policies|
Privacy|
Terms of Use|


John MacLeod - FightCRC

John MacLeod - FightCRC
Skip to content
Patients & Caregivers
About Colorectal Cancer
Our Programs
Get Involved
Search Results:
What are my screening options? Just Diagnosed – Where do I go from here? Dealing with Skin Rash and other Unpleasant Side Effects Report Cards: Understanding Your Biomarker and Pathology Reports View More Results
Donate Now
Patients & Caregivers
Access the information, tools, and support that help you move through colorectal cancer and stay informed at every step.
Learn More
Understanding Your Diagnosis
Break down the details of your diagnosis, including staging, testing, and treatment options, to help you navigate what comes next.
Learn More
Treatment Choices & Checklist
Colorectal Cancer Biomarkers
Upcoming Webinars
Patient & Caregiver Stories
Cancer Terms Glossary
Education & Resources
Explore reliable resources, expert guidance, and practical tools to help you learn more and advocate for your health with confidence.
Learn More
Just Diagnosed
Your Care Team
Surgery & Ostomy
Diagnostic Tests & Scans
Treatment Choices & Checklist
Clinical Trials
Side Effects
Mental Health
Lifestyle & Nutrition
Financial & Insurance Help
Planning Ahead & End of Life
Survivorship
Support Services
Fight CRC’s support services provide the tools, guidance, and community you need to stay informed, supported, and empowered every step of the way.
Learn More
Join the Online Community
Find a Doctor
Ask ChatCRC
Support for Caregivers
LGBTQ+ Support
Colorectal Cancer in Young Adults
Partner Organization Resources
Estate Planning
About Colorectal Cancer
Learn what colorectal cancer is, how it develops, and the key facts, symptoms, and screening guidelines to know.
Learn More
Colorectal Cancer Facts
Get the key facts about colorectal cancer—including who’s affected, why rates are rising in younger adults, and what we know from the latest research and data.
Learn More
What is Colorectal Cancer?
Statistics
How Colorectal Cancer Develops
Your Risk & Prevention Tips
Understand how your personal history, family history, and other risk factors influence your chances of developing colorectal cancer—and learn the steps you can take to stay ahead of it.
Learn More
Genetics & Family History
Signs & Symptoms
Screening Quiz
Screening & Early Detection
Get clear guidance on screening and early detection: which tests are right for you, when to schedule them, how to prepare for a colonoscopy, and insurance coverage.
Learn More
Which Test & When
Colonoscopy Prep
Insurance & Screening Coverage Guide
Our Programs
Explore Fight CRC programs that support you, strengthen your voice, and connect you to research-driven progress.
Learn More
Advocacy
Our Advocacy Program helps you raise your voice, take meaningful action, and advance Fight CRC’s priorities to improve colorectal cancer outcomes.
Learn More
Take Action
Advocacy News & Wins
Policy Priorities
Colorectal Cancer Care Initiative
Annual Lobby Day
Advocacy Training
State Catalyst Program
Research
The Research Program fuels collaboration and patient-centered research to improve outcomes across colorectal cancer care.
Learn More
Research Priorities
Funded Researchers
Clinical Trials
Research Advocacy Training & Support Program
Our Path to a Cure
Events & Campaigns
Discover upcoming Fight CRC events and opportunities to connect, learn, and take action.
Learn More
Call-on Congress
United in Blue
Ambassador Program
Colon Camp
No Shave November
March: Colorectal Cancer Awareness Month
Get Involved
Whether you’re a patient, caregiver, or loved one, Fight CRC offers medically-reviewed resources, support, and community so you never face colorectal cancer alone.
Learn More
Events & Ways to Give
Explore upcoming events and discover meaningful ways to support Fight CRC’s mission.
Learn More
Honor Your Loved One
Host an Event
Join an Event
Support a Survivor
Find Community
Learn More
Join the Online Community
Volunteer
Share Your Story
Raise Awareness From Home
Take Action
Shop
Learn More
Our Mission
News & Media Hub
Our Team
Contact Us
Shop
Impact & Financials
John MacLeod
Love and miss you every minute of every day
READY TO JOIN THE FIGHT?
Subscribe To Our Newsletter Join Our Community
Our Mission
News & Media Hub
Our Team
Contact Us
Shop
Impact & Financials
Faceboook X Instagram YouTube TikTok LinkedIn Bluesky
Policies and Disclaimers
© 2026 Fight Colorectal Cancer. All rights reserved. Tax ID: 20-2622550
Donate Now


Has anyone had surgery to remove scar tissue? | Mayo Clinic Connect

Has anyone had surgery to remove scar tissue? | Mayo Clinic Connect
Skip to Content
Connect
Sign In
Join
Home
Support Groups
Blogs & Podcasts
Events
Members
Help Center
< Head & Neck Cancer
Has anyone had surgery to remove scar tissue?
Posted by mindyt <USER_13>, Oct 24, 2021
I have a lot of scar tissue from radiation leaving me with a challenged airway - it has also ratcheted down on my vocal cords taking my voice as well as painful- I live in an area that the Drs tell me to find a specialist (it’s over their heads) but the idea that I could have improvement would be incredible. I have been seen by 2 ENT surgeons in my state but I don’t think the information was there. So has anyone surviving throat cancer had radiation and surgery to remove scar tissue or anyone with some advice I don’t know where to go from here?
Like
Helpful
Hug
5 Reactions
Copy link to clipboard
Bookmark
Report discussion
Interested in more discussions like this? Go to the Head & Neck Cancer Support Group.
First
1
2
3
4
...
Next
Last
Oldest to Newest Newest to Oldest Most Replied To Most Reacted
stephenrfleury | <USER_14> | 2 days ago
I was treated for my SCC with radiation and chemo. Like many of us, the radiation caused fibrosis and tightening in my neck. To ease the fibrosis and to return some of the mobility, I had a surgery called fat grafting. Prior to the surgery, I began Botox injections in my neck, which which helped on their own. Then I had the fat grafting surgery where they remove fat, in my case my stomach, and inject it into my neck. During that surgery, they also "cut "some some of the fibrous chords in my neck. The net result of these two treatments is near normal movement in my neck, and almost no pain.
Like
Helpful
Hug
5 Reactions
Copy link to clipboard
Bookmark
Report comment
REPLY
omaest | <USER_15> | 3 days ago
I have radiation fibrosis as a result of treatment for tonsil cancer in 2003. This is one of many long term after effects of radiation. The ENT of my tumor team told me that surgery was too much of a risk because of where the scar tissue (fibrosis) is and if removal surgery was done it probably wouldn't heal. The side of my neck is very hard. I have lots of exercises to do and have gone to a number of therapists to keep the tissue from getting stiffer as the years go by.
Like
Helpful
Hug
Copy link to clipboard
Bookmark
Report comment
REPLY
doglover888 | <USER_16> | 4 days ago
Hi. This might help. I had esophageal cancer and due to complications my right vocal cord died. I had an implement inserted in my next which produces sound. This could be an option. Good luck and stay positive.
Like
Helpful
Hug
3 Reactions
Copy link to clipboard
Bookmark
Report comment
REPLY
harleytiger | <USER_17> | Dec 2, 2025
In reply to <USER_18> "<USER_19> wow that’s a lot to take in. My worst 19 hour neck dissections made my..." + (show)- (hide)
<USER_18>
<USER_19> wow that’s a lot to take in. My worst 19 hour neck dissections made my mobility like a wooden neck. I’m only comfortable resting my head from so much muscle loss but knitting has become my best friend.
Jump to this post
<USER_18> Me too. I have the same problem. My neck feels like I have a bungee chord attached from my skull to my top rib. I have hard places in there as well. Mobility is a big problem. Did you have radiation? I think mine is radiation fibrosis. I'm currently going to a great PT who is doing great work on my neck. He believes he can make it much better. Hopefully he's right? I know he works it very well. He said red light hasn't been proven to work and the cost of those machines are so expensive that most PT locations don't have them.
Like
Helpful
Hug
3 Reactions
Copy link to clipboard
Bookmark
Report comment
REPLY
speseas | <USER_18> | Dec 1, 2025
In reply to <USER_19> "Dear <USER_13>, I have had radiation for Pyriform Sinus Cancer. These two pouches, are located down..." + (show)- (hide)
<USER_19>
Dear <USER_13>, I have had radiation for Pyriform Sinus Cancer. These two pouches, are located down by the vocal cords. My pen-pal friend has also had radiation for throat cancer. We both suffer in different ways. Your question about surgery to remove scar tissue is a good one. Here is what we have both been told by several different ENT's: Radiated tissue can become necrotic (rot) if any type of surgery is performed. One ENT described radiated tissue as "mush." Unfortunately, it can become necrotic on its own too. My friend has been on a feeding tube for over two years, as she can not eat, drink, and can barely talk. Her Epiglottis is fused to her throat from the radiation. Any tampering could produce disastrous results. We both have tracheotomies, as my Vocal Cords are paralyzed. I could barely breathe, thus, the Tracheotomy. Everyone is different, but when it comes to radiated tissue, it is a sad situation. As the doctors usually say, "at least you are alive." I foresee the day when less destructive methods are utilized to cure cancer, however, it probably will not be in my lifetime, as I am in my 60s. Good luck Mindy, and know you are not alone. Stay close to our maker, and you will find peace.
Jump to this post
<USER_19> wow that’s a lot to take in. My worst 19 hour neck dissections made my mobility like a wooden neck. I’m only comfortable resting my head from so much muscle loss but knitting has become my best friend.
Like
Helpful
Hug
3 Reactions
Copy link to clipboard
Bookmark
Report comment
REPLY
1 reply
ed69gts | <USER_20> | Mar 2, 2025
And Iam losing my voice and having pain around my face and ear where they put a new tongue in my mouth
Like
Helpful
Hug
1 Reaction
Copy link to clipboard
Bookmark
Report comment
REPLY
ed69gts | <USER_20> | Mar 2, 2025
No my doctor doesn't want to do anything for it
Like
Helpful
Hug
1 Reaction
Copy link to clipboard
Bookmark
Report comment
REPLY
dalestackable | <USER_21> | Jun 24, 2024
Follow up on the small bowel obstructions/from scar tissue of feeding tube. After reviewing the 2 emergency room notes, my surgeon (Ivor Lewis surgery) suggested that I wait and if it happens again, they may go in and do some removal of scar tissue. As I am in Florida, and my surgeon is in Houston, that poses a potential threat due to the time, it would take me to get there. I’m still very concerned because we know removing scar tissue can create more scar tissue.
Has anyone had bowel obstructions following a feeding tube?
I had mine for 6 months.
Concerned because my local emergency room doctors are not receptive to treating me once they see my scat CAT scan and the repositioned organs of my gut. (from the Ivor Lewis surgery) I don’t know how I will be able to get on the plane and go back to Houston if this happens again. Concerned about what could happen in an emergency situation if I have another bowel obstruction .
Like
Helpful
Hug
1 Reaction
Copy link to clipboard
Bookmark
Report comment
REPLY
dalestackable | <USER_21> | Oct 24, 2023
In reply to <USER_22> "I am a 3+ year survivor of Stage IV ESCC. I am totally non-PO due to..." + (show)- (hide)
<USER_22>
I am a 3+ year survivor of Stage IV ESCC. I am totally non-PO due to extensive esophageal strictures. I've undergone 10 dilation but my esophagus is now too friable to attempt further dilations as it would repture. I am totally dependent upon my G tube for meds, nutrition and hydration. I was treated with aggressive chemo-radiation to try to control my disease. Unfortunately, one of rarely discussed side effects of radiation therapy for esophageal, throat and head and neck cancers is reactive fibrosis. While radiotherapy kills the cancer, it also produces free radical reactive oxygen species (ROS) and inflammation which cause tissue fibroblasts near the cancer lesion to produce increased amounts of connective tissue. This results in increased tissue stiffness and rigidity as well as strictures. The throat and esophagus may be amenable to dilation but the relief may be temporary as fibrosis and strictures inevita


IP video intercom kit

IP video intercom kit
The store will not work correctly in the case when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
English
کوردی
العودة إلى آسياسيل
Auto Login
حول آسياسيل الدعم
إستمارة تسجيل الشرکاء
مقارنة المنتجات
الأسئلة الشائعة
السياسة والضمان
Toggle Nav
قائمة طعام
سلة التسوق
Auto Login
لغة
English
کوردی
إستمارة تسجيل الشرکاء
مقارنة المنتجات
الأسئلة الشائعة
السياسة والضمان
آسيامول
موبايل
القسائم الالكترونية
حاسوب
ألعاب
إلكتروني
ملحقات
أجهزة منزلية
منتجات آسياسيل
حساب
تسجيل الدخول
سلة التسوق
يبحث
يبحث
يبحث
الصفحة الرئيسية
آسيامول
الحماية الذكية
Hikvision
IP video intercom kit
Close
This is error message
IP video intercom kit
متوفر
يشارك
يشارك يشارك
كن أول من يراجع هذا المنتج
الكمية:
EZVIZ
أضف لسلة التسوق
244,950 دينار
أضف للمقارنة
انتقل إلى النهاية معرض الصور
تخطي إلى بداية معرض الصور
نظرة عامة على المنتج
Network video intercom bundle for villa or house
One call button for easier calls
Convenient Hik-Connect App mobile control
Stores messages and captured pictures in the TF card
Including: DS-KV8113-WME1(C) × 1, DS-KH6320-WTE1 × 1, 4-port standard PoE switch × 1, 16 GB TF card × 1
Power adapter included in the package
ملاحظات
التقييمات والمراجعات
كن أول من يراجع هذا المنتج
0
0
0
0
0
اكتب مراجعة
یرجی تسجيل الدخول لکتابة ملاحظاتك القیمة حول منتجاتنا. تسجيل الدخول أو إنشاء حساب
Buy Electronics, devices & More | Asia Mall by Asiacell – Iraq's Online Shopping
تم بيعها من قبل
EZVIZ
18 Products
تواصل مع البائع
تواصل مع البائع
Close
اسمك : بريدك الالكتروني : العنوان : طلبك :
رابط سريع
الدفع السريع / إعادة الشحن
خدمة المشتركين
إستمارة تسجيل الشرکاء
مساعدة
حسابي
تاريخ الطلبات
العناوين
عربة التسوق
ملفي
تتبع طلبك
معلومات الشركة
الشروط والأحكام
حمل تطبيق آسياسيل
حول آسياسيل
الأسئلة الشائعة
السياسة والضمان
حمل تطبيق آسياسيل
جميع حقوق النشر محفوظة لآسیاس
التواصل معنا على


Optical Properties of dendritic agate | Luster

Optical Properties of dendritic agate | Luster
×
dendritic agate
☒
Top
ADD ⊕
Compare
Gemstones
Gems for Taurus
Gems for Gemini
Gems for Leo
Organic
Gems for Aries
Gems for Cancer
Gems for Libra
Gems for Capricorn
⌕
▼
Optical Properties of dendritic agate
dendritic agate
Add ⊕
Summary
Astrology
Physical Properties
Optical Properties
Benefits
All
Optical Properties
Luster
-
Pleochroism
-
Dispersion
0.01
Rank: 60 (Overall)
0.005 1
👆🏻
Transparency
TranslucentWalter Schumann
Refractive Index
-9999
1 3.25
👆🏻
Optic Character
-
Crystal System
-
Birefringence
-9999
0 0.296
👆🏻
Clarity
TranslucentWalter Schumann
dendritic agate Luster
Optical Properties of dendritic agate are its behavioral responses towards light. While few optical properties can be identified with naked eyes, other require special instruments by the gemologists to identify them. dendritic agate optical properties like luster, clarity, refractive index etc. are used to determine the non-destructive methods during gemstone identification and evaluation.
dendritic agate luster is the quantity of light the crystal reflects when light is incident on it. dendritic agate which is commonly found in White, Colorless, Blue, Red, Green, Yellow, Violet color, is TranslucentWalter Schumann in nature.
Blue Gemstones
Grossular Garnet
Andradite Garnet
Indicolite
Orbicular jasper
Plasma
Blue spinel
dendritic agate Refractive Index
Optical properties of a dendritic agate crystal are responsive to the small changes in composition and strain within its crystalline structure. Absolute diligence is therefore necessary during cutting and polishing of the gemstone. All such optical properties are majorly influenced by Physical Properties of dendritic agate.
As we are well aware, refractive index is the phenomenon which is related to bending of light through a medium (crystal). It is used in qualitative analysis of gemstones by gemologists Besides, few gemstones exhibit property of dual refractive indices. This dual nature is known as Birefringence. So if you are searching for prominent Blue Gemstones, dendritic agate gem is something not miss on, since it has been a favorite pick in the gem wearing community.
Compare Blue Gemstones
Grossular Garnet Vs Plasma
Grossular Garnet Vs Blue spinel
Grossular Garnet Vs Trapiche emerald
Trapiche emerald
Astrology | Physical ... | Optical P... | Benefits
Lemon quartz
Astrology | Physical ... | Optical P... | Benefits
Rutilated topaz
Astrology | Physical ... | Optical P... | Benefits
Andradite Garnet Vs Grossular...
Astrology | Physical ... | Optical P... | Benefits
Indicolite Vs Grossular Garnet
Astrology | Physical ... | Optical P... | Benefits
Orbicular jasper Vs Grossular...
Astrology | Physical ... | Optical P... | Benefits
Home |
About |
Contact |
Disclaimer |
Terms of Use |
Privacy Policy
© 2015 - 2026 www.compareusvista.com
Developed & Maintained by softUsvista Inc.


Subjects: Cerebral Cortex -- pathology - Digital Collections - National Library of Medicine Search Results

Subjects: Cerebral Cortex -- pathology - Digital Collections - National Library of Medicine Search Results
Skip to search Skip to main content Skip to first result
An official website of the United States government. Here’s how you know
Official websites use .gov
A .gov website belongs to an official government organization in the United States.
Secure .gov websites use HTTPS
A lock ( Lock
A locked padlock ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.
search for
Search
About
Help
Web Service
Search
Search Constraints
Start Over You searched for: Subjects Cerebral Cortex -- pathology ✖ Remove constraint Subjects: Cerebral Cortex -- pathology
1 - 4 of 4
Sort by title
relevance title
Number of results to display per page
10 per page per page
10 per page 20 per page 50 per page 100 per page
Search Results
1. Cases illustrating cortical paralysis with loss of speech
Author(s):
Greenlees, T. Duncan (Thomas Duncan), 1858- author
Publication:
[Utica, N.Y.?] : [publisher not identified], [1887?]
Subject(s):
Cerebral Cortex -- pathology
Paresis
Aphasia
2. On arrested cerebral development with special reference to its cortical pathology
Author(s):
Sachs, Bernard, 1858-1944
Publication:
New York : [s.n.], 1887
Subject(s):
Brain -- abnormalities
Cerebral Cortex -- pathology
Infant
3. Some minor studies in nerve cell degeneration as presented by a case of localized cerebral atrophy
Author(s):
Prout, Thomas P., author
Publication:
[Baltimore?] : [publisher not identified], [1895?]
Subject(s):
Cerebral Cortex -- pathology
Atrophy
Nerve Degeneration
4. Studies on the lesions produced by the action of certain poisons on the nerve cell. Part II, Experimental lesions produced by the action of dog's serum on the cortical nerve-cell of the rabbit's brain : preliminary paper
Author(s):
Berkley, Henry J. (Henry Johns), 1860-1940 author
Publication:
Philadelphia : Lea Brothers & Co., [1895?]
Subject(s):
Neurons -- pathology
Cerebral Cortex -- pathology
Serum
Refine by:
Show facets Hide facets
Formats
Text4
Collections
Medicine in the Americas, 1610-19204
Subjects
Cerebral Cortex -- pathology✖[remove]4
Aphasia1
Atrophy1
Brain -- abnormalities1
Infant1
more Subjects »
Authors
Berkley, Henry J. (Henry Johns), 1860-1940 author1
Greenlees, T. Duncan (Thomas Duncan), 1858- author1
Prout, Thomas P., author1
Sachs, Bernard, 1858-19441
Titles
Cases illustrating cortical paralysis with loss of speech1
On arrested cerebral development with special reference to its cortical pathology1
Some minor studies in nerve cell degeneration as presented by a case of localized cerebral atrophy1
Studies on the lesions produced by the action of certain poisons on the nerve cell. Part II, Experimental lesions produced by the action of dog's serum on the cortical nerve-cell of the rabbit's brain : preliminary paper1
Languages
English4
Genre
Case Reports3
Copyright
Public domain4
Dates by Range
1850-18994
Publication Year
Begin
End
1000 to 10990
1100 to 11990
1200 to 12990
1300 to 13990
1400 to 14990
1500 to 15990
1600 to 16990
1700 to 17990
1800 to 18994
1900 to 19990
2000 to 20260
Connect with NLM
National Library of Medicine
8600 Rockville Pike
Bethesda, MD 20894
Web Policies
FOIA
HHS Vulnerability Disclosure
NLM Support Center
Accessibility
Careers
NLM | NIH | HHS | USA.gov


ХОБЛ: какие методы лечения эффективны?- Patient Information | BMJ Best Practice

ХОБЛ: какие методы лечения эффективны?- Patient Information | BMJ Best Practice
Skip to main contentSkip to search
English (US)EnglishPortuguês
Log in
Personal account
Access through your institution(Open Athens)
Subscribe
Access through your institution
Log in
English (US)EnglishPortuguês
Home
Search
Search
Home
About us
OverviewWhat is BMJ Best Practice?Our history
Key featuresClinical tools Local guidanceEarn CME/CPD pointsAccess anywhereOur appIntegration
Our Evidence approachTrusted contentUpdating process
Who we help
Best Practice for...CliniciansHospitalsMedical librariansMedical schoolsMedical studentsNursesPharmacistsPrimary careParamedicsTelehealth
How we help
Impact and effectivenessEvidence of effectiveness Global impactCustomer stories
Browse clinical content
Recent updates
Specialties
Try a free topic
Patient information
Videos
Calculators
What’s new
Clinical updates
News
Podcast
Access
Log in via...Personal subscription or user profileAccess through your institution
Access code
Subscribe
Free trial
How do I get access?
Download the app
Help
FAQs
How do I get access?
Contact us
Patient information
Patient information from BMJ
PrintDownload PDF
ХОБЛ: какие методы лечения эффективны?
Last published:Dec 06, 2021
COPD stands for chronic obstructive pulmonary disease. It means that lung damage is stopping your lungs working as well as they used to. There is no cure but there are treatments that can help stop it getting worse.
You can use our information to talk to your doctor and decide which treatments are right for you.
What treatments work?
If you have COPD the airways in your lungs have been damaged over many years. This damage is usually caused by smoking. But other things can cause COPD, including:
breathing in other poisonous chemicals (possibly through long exposure to severe air pollution), and
some inherited genetic conditions.
The aims of treatment for COPD are:
to prevent and control symptoms
to reduce the number of exacerbations (this is when your symptoms suddenly get worse) you have and to make them less severe.
to help your lungs to work better, and
to help you live a longer and healthier life.
Your treatment should include regular appointments with your doctor to check on your progress. Your doctor should make sure that you understand:
what COPD is, and
how to recognise an exacerbation.
Stopping smoking
These days, the main cause of COPD is smoking. Stopping smoking can:
slow down the damage COPD does to your lungs
reduce your chance of cancer and heart problems related to COPD
help you live longer with a better quality of life.
Of course, stopping smoking is not easy, especially if you have smoked for many years. So your doctor may recommend a stop-smoking programme to help you stop. This may include counselling, group meetings, and medication.
For more information on ways to help you stop smoking, see our leaflet Stopping smoking.
Staying healthy
Your doctor might discuss self-management with you. This doesn't mean that you have to take care of yourself, without medical care. It means that you are helped to learn about COPD so that you can help control it.
People who learn to self-manage their COPD tend to need less hospital treatment.
Self-management plans that you discuss with your doctor should include learning about:
managing breathlessness
managing stress
conserving energy
avoiding things that make your symptoms worse
the right types of exercise for people with COPD (and specifically for you), and
contact information to use if you have an exacerbation.
Some people are able to take part in a lung-care programme. They're usually called pulmonary rehabilitation programmes).
These programmes are usually organised in hospitals. You'll learn about how your lungs work and how to do exercises that make them stronger. You'll need to keep doing these exercises at home, after your programme finishes.
You'll also learn about your medicines and the best way to take them. Ask your doctor if there’s a local programme near you.
Taking part in a programme can:
reduce your chance of needing hospital treatment
reduce the depression and anxiety that sometimes go along with COPD
reduce fatigue
increase how much you are able to exercise
help improve your quality of life: for example, by helping you feel more in control of your life and your illness.
Regular exercise can help you stay healthy. Even gentle exercise, such as walking, can help you get fitter and do more of the things you enjoy. Everyone with COPD should try to do as much exercise as they can to keep their lungs as fit as possible.
It's also important to get your flu and pneumonia jabs (vaccinations). If you have COPD, getting flu or pneumonia can be very serious. Talk to your doctor and make sure you get protected. You need a new flu jab every year.
Medicines you breathe in
Many types of medicine are used to treat people with COPD, depending on what works best for each person. Here, we look at the main ones.
The first treatment you get for COPD will probably be an inhaler, just as you would use if you had asthma. Breathing in medicine through an inhaler helps to open up the airways in your lungs and make breathing easier.
There are several kinds of inhaler, so if you find yours hard to use, talk to your doctor. He or she will be able to suggest a different type.
Several types of medication can help relieve the symptoms of COPD when inhaled.
Bronchodilators are drugs that help to open up the airwaves by relaxing the muscles around the lungs. There are different kinds: some work quickly to give you fast relief from symptoms and others have a more long-term effect.
You may hear your doctor refer to these as short-acting and long-acting drugs. Bronchodilators that you might be prescribed include:
drugs called beta agonists. These drugs help relax the muscles in the lungs. There are short-acting and long-acting versions.
anticholinergic drugs. These help relax the muscles in the lungs in a slightly different way from bronchodilators. They also come in short- and long-acting versions.
Other drugs are available if the main ones don't work well enough, but they are less commonly used.
Bronchodilators can cause side effects in some people. For example, bronchodilators called beta-2 agonists may make your hands tremble, or they may make your heart beat faster, especially if you already have a heart problem.
Taking a beta-2 agonist for a long time slightly raises your chance of heart problems, so your doctor should monitor you regularly.
If you've already tried short-acting and long-acting inhalers and you still get symptoms, your doctor may suggest you use a steroid inhaler (the full name is corticosteroid). You use this along with a bronchodilator. You may be able to use a single inhaler that contains both drugs.
Corticosteroids help open your airways by reducing inflammation in the lungs. They can help reduce exacerbations and may even help you live longer.
But they are only recommended for people with advanced COPD who have frequent exacerbations. This is because corticosteroids can cause serious side effects.
The most common side effect is a fungal infection (thrush) in the mouth or throat. It can usually be avoided by gargling with water after each puff. Other possible side effects include weakened bones and easy bruising, but these are more common with steroid tablets than with the inhaled versions.
Corticosteroids can also increase your chances of getting pneumonia. So your doctor will be cautious about prescribing them if he or she thinks you are at high risk of pneumonia.
Doctors use what's called a 'stepwise' approach for COPD medications. This means that you start on the lowest possible dose of medicine that's suitable for the severity of your symptoms. Your doctor can then increase or reduce the dose or number of drugs you use, depending on what helps you most.
For your first 'step' you'll probably use a fast-acting inhaler. You can use this for quick relief when you get


Asiacell Products - Mobiles & Tablets - iTunes - Black Titanium

Asiacell Products - Mobiles & Tablets - iTunes - Black Titanium
The store will not work correctly in the case when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
عربى
کوردی
Back To Asiacell
Auto Login
About Asiacell Support
Partner Registration Form
Compare Products
FAQ
Return & Exchange Policy
Toggle Nav
Menu
My Cart
Auto Login
Language
عربى
کوردی
Partner Registration Form
Compare Products
FAQ
Return & Exchange Policy
Asiamall
Mobile
Digital Vouchers
Computer
Gaming
Electronic
Accessories
Home Appliances
Asiacell Products
Account
LOG IN
My Cart
Search
Search
Search
Home
Asiamall
Asiacell Products
Asiacell Products
Asiacell Products
Special Offer
Mobiles & Tablets
Digital Vouchers
Accessories
Air & Travel
Smartwatches
Smart Security
Laptops & PC
Gaming
Home Appliances
Watches
All Phones
Eufy
Xiaomi
Honor
Shop By
Clear All
Buy Electronics, devices & More | Asia Mall by Asiacell – Iraq's Online Shopping
Access to Partner Services
You're now being re-directed to access services provided by our trusted partner. Please note that all service delivery, support, and terms are managed by the partner. We encourage you to review their terms and conditions. Click Continue to proceed.
We can't find products matching the selection. Please click here to reset filter
Filters
All Devices
Now Shopping by
Category Mobiles & Tablets Remove This Item
Voucher Sub-category iTunes Remove This Item
Color Black Titanium Remove This Item
Clear All
Shopping Options
Quick Link
Quick pay/Recharge
Partner Registration Form
Customer Service
Help
My Account
Order History
Addresses
Shopping Cart
My Profile
Track your order
Corporate Info
Terms & Conditions
Download the Asiacell App
About Asiacell
FAQ
Policy & Warranty
Download the Asiacell App
© Asiacell 2023 to 2025. All rights reserved.
Connect with us on


Kyanite and Hessonite Garnet Physical Properties

Kyanite and Hessonite Garnet Physical Properties
×
Kyanite
☒
Hessonite Garnet
☒
Top
ADD ⊕
Compare
Gemstones
Gems for Taurus
Gems for Gemini
Gems for Leo
Organic
Gems for Aries
Gems for Cancer
Gems for Libra
Gems for Capricorn
⌕
▼
X
Kyanite
X
Hessonite Garnet
Kyanite and Hessonite Garnet Physical Properties
Kyanite
Hessonite Garnet
Add ⊕
Summary
Astrology
Physical Properties
Optical Properties
Benefits
All
Physical Properties
Tenacity
Brittle
-
Solubility
-
-
Durability
-
-
Specific Gravity
3.53-3.65-9999
1 7.18
👆🏻
Fracture
Splintery
-
Cleavage
[100] perfect [010] imperfect with 79° angle between
None
Mohs Hardness
4-7-9999
2 10
👆🏻
Chemical Composition
Al2SiO5
Ca3Al2(SiO4)3
Kyanite and Hessonite Garnet Chemical Formula
While comparing Kyanite and Hessonite Garnet physical properties, the important data you should know is its chemical composition. Since chemical formula defines the molecular structure of the crystal, most of the physical properties like color, tenacity, solubility are governed by Kyanite and Hessonite Garnet chemical formula.
Chemical formula of Kyanite- Al2SiO5
Chemical formula of Hessonite Garnet- Ca3Al2(SiO4)3
Compare Gems for Aries » More
Kyanite Vs Jade
Kyanite Vs Hematite
Kyanite Vs Garnet
» More Compare Gems for Aries
Kyanite and Hessonite Garnet Specific Gravity
Another important criteria for qualitative analysis of gemstones is Kyanite and Hessonite Garnet Specific gravity. Specific gravity is the relative density of a gemstone compared with respect to density of water. Gemologists use Kyanite and Hessonite Garnet Optical Properties during the identification of gemstone. Specific gravity of Kyanite is whereas that of Hessonite Garnet is .
Gems for Aries » More
Apache Tear
Bixbite
Bloodstone
Jasper
Jade
Hematite
» More Gems for Aries
Gems for Aries » More
Garnet
Astrology | Physical ... | Optical P... | Benefits
Emerald
Astrology | Physical ... | Optical P... | Benefits
Aventurine
Astrology | Physical ... | Optical P... | Benefits
Compare Gems for Aries » More
Hessonite Garnet Vs Bixbite
Astrology | Physical ... | Optical P... | Benefits
Hessonite Garnet Vs Bloodstone
Astrology | Physical ... | Optical P... | Benefits
Hessonite Garnet Vs Jasper
Astrology | Physical ... | Optical P... | Benefits
Home |
About |
Contact |
Disclaimer |
Terms of Use |
Privacy Policy
© 2015 - 2026 www.compareusvista.com
Developed & Maintained by softUsvista Inc.


Jewellery for your feet - Silver Ethnic Anklets | Stylish By Nature By Shalini Chopra | India Fashion Style Blog | Beauty | Travel | Food | Bollywood

Jewellery for your feet - Silver Ethnic Anklets | Stylish By Nature By Shalini Chopra | India Fashion Style Blog | Beauty | Travel | Food | Bollywood
Home
About
Contact
Awards
Home
Fashion
Food N Wine
Travel
Beauty
Lifestyle
Bollywood
Events
Technology
My Lookbook
Lookbook 19-20
Lookbook 2018
Lookbook 2017
Lookbook 2016
Lookbook 2015
Lookbook 2014
Lookbook 2013
Shop My Closet
SBN Club
#Trend
Loading...
Home / 2013 maxi dresses / Accessories trend 2013 / best fashion blog india / casual street style for women in india / contest or sweepstakes / online shopping site / Jewellery for your feet - Silver Ethnic Anklets
Jewellery for your feet - Silver Ethnic Anklets
2013 maxi dresses , Accessories trend 2013 , best fashion blog india , casual street style for women in india , contest or sweepstakes , online shopping site
Hi Everyone,
The essential jewellery for your feet: Silver Anklets
Anklets have an extensive and huge demand in the world. With passage of time, women from many civilizations used ankle bracelets to form a sexy look, show their affluence, indicate marital status, draw a suitor, and draw the attention to their pretty, well groomed, feet. Certainly, the use of anklets may have been the precursor to the contemporary pedicure, painted toenails, and high heels.
From the very old Sumerians in Mesopotamia over 4000 years ago came the initial proof of the use of ankle bracelets.
In Ancient Egypt, both the wealthy and deprived wore anklets. The wealthy wore anklets ornamented with precious stones and made from high-priced metals, while the poor used them to exhibit charms and amulets. In the earlier period, all through the Middle East, the anklets were frequently associated by a stretch of chain to make a shorter, feminine step.
The ankle bracelet originally became admired in the United States in the 1950's, and saw a resurgence in esteem in the 1970's as women began wearing bracelets with their name or initials on them.
In adding up to their use in the twenty-first century amid the fashionable, ankle bracelets have also taken on a useful turn for some. Police and the judicial system have turned to anklets in order to check the activities of the criminal, the rehabilitated, and those in need of rehabilitation. Modern ankle bracelets can offer a GPS location of their wearer to the judicial system or a parole officer, permitting better monitoring of their activities.
But the richest account of anklets may have developed in India. Anklets were an imperative tradition used to sign marital status and still are an essential part of ceremonial wedding garments.
But marriage and relationship standing weren't the only things which anklets were used for in history. Indian women also attached anklets with bells during dances to produce a striking jingle to go with their movements. The use of ankle bracelets as an ornament to a dance costume was also seen among belly dancers in the Middle East, who generally wore elaborate jewellery along with their outfits.
Anklets have been in use since ages and the delicate attractiveness of a woman's anklets get multiplied when decorated with a pair of exclusively designed anklets, ideal piece of art. They can effortlessly gel well with both recognized and informal wears and has become a quite fashion rage amongst all age groups, particularly the teenage group.
Conventionally in use, anklets have even taken up the contemporary fashion world with a storm and they are being worn by both adolescent and unmarried women in India.
The anklets come with adoring accompaniments, intricate carvings and other fine artistry effortlessly done on metal. Previously the anklets were made of silver or brass but their attractiveness has made the manufacturers try out other metals and experiment with conventional and modern designs.
Silver anklets with semi precious stones like garnets, topaz, Amethyst, aqua marine and others are a fashionable way of adorning your legs and adding colour to your outfit in the summers.
Till next time....Keep it STYLISH By Nature !!
Join Me on
FACEBOOK | TWITTER | BLOGLOVIN
Share on Facebook Share on Twitter Share on Google Plus
RELATED POSTS >>>
RELATED POSTS
Blogger Comment
Facebook Comment
Newer Post Older Post Home
Featured Video
IIFA New York - Vlog
Popular Posts
Styling Tips for Cocktail Party Dresses
Hi Everyone, Backless Maxi Cocktail Dress - 6ks Peep-Toe Heels - OASAP (available in 2 colors) Sapphire and Spikes Bracelet - You...
Featured Blog of the Week - Look10
Hi Everyone, Thrilled to share that 'Stylish By Nature' is featured as the 'Blog of the Week' at Look10. ...
COACH STORE IN UB City BANGALORE
Hi Everyone, COACH OPENS NEW STORE IN UB City, BANGALORE Coach, a global design house of modern luxury leather goods, apparel and...
Fashion Trend Pastels and Neons 2013
Hi Everyone,
Christmas New Year 2012 Sequin heels dress party
Hi Everyone,
Ready for the SPRING !!
Hello Everyone, Spring/Summer 2012 is in wings and all we fashionistas are already shopping to ready our wardrobe for the upcoming seaso...
Fashion Trend: Jumpsuits this Summer
Hi Everyone,
Twitter
Tweets by <USER_17>
© StylishByNature 2011-2014. Powered by Blogger.
Copyright © 2014 Stylish By Nature By Shalini Chopra | India Fashion Style Blog | Beauty | Travel | Food | Bollywood


Lisdexamfetamine - AdisInsight

Lisdexamfetamine - AdisInsight
Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?
Skip to main content
Welcome to AdisInsight
Register your email address to show your organization how much you value your AdisInsight subscription.
With your consent we’ll provide this information to your organization’s account administrator to aid in the renewal decision and we will send you important updates about AdisInsight.
Please refer to our privacy policy for information on how we protect your personal information.
Enter e-mail address here Enter valid e-mail address
You will receive an email to validate your email address. You will see this pop-up again if your browser cookies are cleared on your computer.
Provide Consent
Decline Consent
Welcome to AdisInsight
Close
Verification link has been sent to the e-mail address entered below. Click on that link to proceed.
Change email ID
Resend link
X
Ask the expert
Do you need help? Please contact one of our AdisInsight experts. We aim to get back to you with personalized answer within 24 hours.
Full name *
Email address *
Question / Comment *
Submit
Thank you
Our team would reach out to you shortly in response for your query.
Return to homepage
Login
Username/Password
Institution access
Insight Hub New
APIs
Contact Us
Help
Request demo
Insight Hub New
APIs
Contact Us
Help
Login
Username/Password Institution access
Request demo
Search filter dropdown Select a filter
Drug Name
Indication
Mechanism
Drug Class
Adverse Event
All Text
Search Cancel Search
Drug Safety : ADR Category 1
Lisdexamfetamine
Paralytic ileus: case report
Serious
An event is determined to be serious (based on the ICH definition) when the patient outcome is:
death
life-threatening
hospitalisation
disability
congenital anomaly
other medically important event
Release Date: 22 Apr 2025 Update Date: 22 Apr 2025
Price :
$20 *
Buy Profile
Note:
Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our drug safety profile at the time of purchase.
A link to download a PDF version of the drug safety profile will be included in your email receipt.
You need to be a logged in or subscribed to view this content
Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following:
Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)
If your organization has a subscription, there are several access options, even while working remotely:
Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days
For assistance, contact us at <EMAIL_7>
Scientifically curated records
About our content
Drugs
Trials
Safety Reports
Deals
Patents
Insight Hub
APIs
Dashboards
Other sites
Springer.com
SpringerLink
Springer for R&D
SpringerProtocols
SpringerMaterials
SpringerReference
Help & Contacts
Contact us
Help
Downloads
BizInt setup(windows only)
Legal
Privacy policy, disclaimer, general terms & conditions
Terms of Use
Your US state privacy rights
Cookie policy
Your privacy choices/Manage cookies
Adis International Ltd. Part of Springer Science+Business Media
© Springer Nature Switzerland AG
© 2026 Springer Nature Switzerland AG, Part of Springer Nature
Back to top